AR Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

AR Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.54M	Hold	74,774	–	–	0.88%	34
2025 Q4	$4.03M	Hold	74,774	–	–	0.82%	35
2025 Q3	$3.37M	Hold	74,774	–	–	0.71%	38
2025 Q2	$3.46M	Buy	74,774 +15,000	+25%	+$736K	0.77%	39
2025 Q1	$3.65M	Hold	59,774	–	–	0.83%	38
2024 Q4	$3.38M	Hold	59,774	–	–	0.77%	41
2024 Q3	$3.09M	Hold	59,774	–	–	0.69%	43
2024 Q2	$2.48M	Hold	59,774	–	–	0.6%	45
2024 Q1	$3.24M	Hold	59,774	–	–	0.79%	40
2023 Q4	$3.07M	Hold	59,774	–	–	0.81%	41
2023 Q3	$3.47M	Hold	59,774	–	–	0.97%	36
2023 Q2	$3.82M	Sell	59,774 -450	-0.7%	-$30.2K	1.03%	34
2023 Q1	$4.17M	Hold	60,224	–	–	1.12%	29
2022 Q4	$4.33M	Hold	60,224	–	–	1.23%	29
2022 Q3	$4.28M	Buy	60,224 +300	+0.5%	+$21.8K	1.28%	26
2022 Q2	$4.61M	Hold	59,924	–	–	1.3%	25
2022 Q1	$4.38M	Hold	59,924	–	–	1.11%	29
2021 Q4	$3.74M	Hold	59,924	–	–	0.95%	33
2021 Q3	$3.55M	Hold	59,924	–	–	0.99%	33
2021 Q2	$4M	Hold	59,924	–	–	1.12%	30
2021 Q1	$3.78M	Hold	59,924	–	–	1.13%	28
2020 Q4	$3.72M	Sell	59,924 -8,000	-12%	-$492K	1.2%	27
2020 Q3	$4.09M	Hold	67,924	–	–	1.44%	20
2020 Q2	$3.99M	Hold	67,924	–	–	1.51%	20
2020 Q1	$3.79M	Buy	67,924 +8,000	+13%	+$489K	1.56%	20
2019 Q4	$3.85M	Hold	59,924	–	–	1.29%	24
2019 Q3	$3.04M	Hold	59,924	–	–	1.07%	30
2019 Q2	$2.72M	Hold	59,924	–	–	0.98%	31
2019 Q1	$2.86M	Hold	59,924	–	–	1.07%	29
2018 Q4	$3.12M	Hold	59,924	–	–	1.34%	23
2018 Q3	$3.72M	Hold	59,924	–	–	1.37%	23
2018 Q2	$3.32M	Hold	59,924	–	–	1.29%	25
2018 Q1	$3.79M	Hold	59,924	–	–	1.53%	22
2017 Q4	$3.67M	Hold	59,924	–	–	1.41%	23
2017 Q3	$3.82M	Hold	59,924	–	–	1.51%	20
2017 Q2	$3.34M	Hold	59,924	–	–	1.36%	23
2017 Q1	$3.26M	Hold	59,924	–	–	1.35%	22
2016 Q4	$3.5M	Hold	59,924	–	–	1.49%	19
2016 Q3	$3.23M	Hold	59,924	–	–	1.4%	19
2016 Q2	$4.41M	Sell	59,924 -16,900	-22%	-$1.19M	1.85%	17
2016 Q1	$4.91M	Sell	76,824 -1,500	-2%	-$94.6K	2.13%	13
2015 Q4	$5.39M	Sell	78,324 -2,520	-3%	-$167K	2.45%	11
2015 Q3	$4.79M	Hold	80,844	–	–	2.13%	14
2015 Q2	$5.38M	Hold	80,844	–	–	2.2%	12
2015 Q1	$5.21M	Hold	80,844	–	–	2.09%	13
2014 Q4	$4.77M	Sell	80,844 -2,000	-2%	-$113K	1.92%	15
2014 Q3	$4.24M	Hold	82,844	–	–	1.72%	18
2014 Q2	$4.02M	Hold	82,844	–	–	1.61%	19
2014 Q1	$4.3M	Hold	82,844	–	–	1.8%	17
2013 Q4	$4.4M	Hold	82,844	–	–	1.87%	16
2013 Q3	$3.83M	Hold	82,844	–	–	1.7%	18
2013 Q2	$3.7M	Buy	+82,844	New	+$3.6M	1.66%	17

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AR Asset Management's BMY Position: Q1 2026 in Review

AR Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 74,774 shares worth $4.54M. The position accounts for 0.88% of the portfolio, ranked #34.

AR Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.39M in Q4 2015. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

AR Asset Management held 74,774 shares of Bristol-Myers Squibb worth $4.54M as of Q1 2026.
AR Asset Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.88% of AR Asset Management's portfolio in Q1 2026, its #34 holding.
AR Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
AR Asset Management's Bristol-Myers Squibb position peaked at $5.39M in Q4 2015.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on AR Asset Management's 13F filing for Q1 2026, filed 13 May 2026.